Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design

The Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA, NCT00911508)(1) trial is testing the hypothesis that the treatment strategy of percutaneous left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) is superior to current state-of...

Descripción completa

Detalles Bibliográficos
Autores principales: Packer, Douglas L., Mark, Daniel B., Robb, Richard A, Monahan, Kristi H., Bahnson, Tristram D., Moretz, Kathleen, Poole, Jeanne E., Mascette, Alice, Rosenberg, Yves, Jeffries, Neal, Al-Khalidi, Hussein R., Lee, Kerry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517320/
https://www.ncbi.nlm.nih.gov/pubmed/29754661
http://dx.doi.org/10.1016/j.ahj.2018.02.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517320/
https://www.ncbi.nlm.nih.gov/pubmed/29754661
http://dx.doi.org/10.1016/j.ahj.2018.02.015

Ejemplares similares